Switzerland
# |
Name |
Current Liabilities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 5.70 B
|
Dec. 31, 2023 | USD 48.28 | 3.35% |
|
Switzerland |
|
2 |
USD 194.76 M
|
Dec. 31, 2023 | USD 26.45 | -1.05% |
|
Switzerland |
|
3 |
USD 67.67 M
|
Dec. 31, 2023 | USD 1.68 | -2.33% |
|
Switzerland |
|
4 |
USD 56.53 M
|
Dec. 31, 2023 | USD 45.08 | 2.29% |
|
Switzerland |
|
5 |
USD 17.12 M
|
Dec. 31, 2023 | USD 4.99 | 1.08% |
|
Switzerland |
|
6 |
USD 16.12 M
|
Dec. 31, 2023 | USD 2.75 | 1.85% |
|
Switzerland |
|
7 |
USD 9.97 M
|
Dec. 31, 2023 | USD 45.99 | -2.40% |
|
Switzerland |
The Vaccines company in Switzerland with the highest Current Liabilities is Sandoz Group AG (Swiss Stock Exchange: SDZ.SW) at USD 5.70 B.
The Vaccines company in Switzerland with the lowest Current Liabilities is MoonLake Immunotherapeutics (NasdaqCM: MLTX) at USD 9.97 M.
The top 10 Vaccines companies in Switzerland by Current Liabilities are Sandoz Group AG, PolyPeptide Group AG, ADC Therapeutics SA, Basilea Pharmaceutica AG, Molecular Partners AG, AC Immune SA and MoonLake Immunotherapeutics.
The bottom 10 Vaccines companies in Switzerland by Current Liabilities are MoonLake Immunotherapeutics, AC Immune SA, Molecular Partners AG, Basilea Pharmaceutica AG, ADC Therapeutics SA, PolyPeptide Group AG and Sandoz Group AG.